How to Identify Key Targets in Protein-Protein Interaction Networks?
In protein-protein interaction (PPI) networks, identifying key targets is essential for elucidating biological processes, understanding disease mechanisms, and developing potential therapeutic strategies. Below is a systematic approach to identifying key targets within PPI networks:
Construction of the PPI Network
Retrieve protein-protein interaction data from databases (e.g., STRING, BioGRID) and bolster its reliability through experimental validations (e.g., yeast two-hybrid, mass spectrometry analysis). Subsequently, construct the network using visualization tools such as Cytoscape.
Network Topology Analysis
Assess the importance of nodes by applying metrics such as degree centrality, betweenness centrality, and closeness centrality to pinpoint critical proteins within the network.
Module and Subnetwork Analysis
Detect functional modules within the network using algorithms like MCL and MCODE, and subsequently identify key proteins within these modules as potential targets.
Integration of Biological Functions and Disease Associations
Utilize functional annotations (e.g., GO, KEGG) and disease association data (e.g., GWAS) to confirm the roles of key proteins in biological processes and disease contexts.
Integration of Multi-Omics Data
1. Gene Expression Data
Incorporate RNA-Seq or microarray data to analyze the expression patterns of genes encoding key proteins, ensuring that these genes exhibit significant differential expression under specific conditions or disease states.
2. Protein Modifications
Evaluate post-translational modifications (e.g., phosphorylation, acetylation) of key proteins, as these modifications can influence their function and interactions within the network.
Experimental Validation
1. Co-Immunoprecipitation (Co-IP)
Validate the physical interactions among key proteins.
2. RNA Interference (RNAi) or CRISPR-Cas9
Employ gene knockdown or knockout techniques to assess the impact of key targets on cellular phenotypes and on the network’s overall protein interactions.
3. Functional Assays
Conduct experiments such as cell proliferation and apoptosis assays to evaluate the biological roles of these targets.
Case Analysis
Using the breast cancer PPI network as an example, the network is constructed with Cytoscape, and metrics such as degree centrality and betweenness centrality are computed using CytoHubba. High-centrality proteins-such as ERBB2 (HER2), TP53, and EGFR-are identified as potential key targets. Further analysis integrating gene expression data reveals that these proteins are significantly upregulated in breast cancer patients and closely associated with patient prognosis. Finally, Co-IP confirms the direct interaction between ERBB2 and EGFR, thereby substantiating their role in breast cancer.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
